Today's Must Read
EOG Resources (EOG) Q1 Earnings in Line, Revenues Beat
Abbott Labs (ABT) Progresses on Approvals & Solid Prospects
Tuesday May 16, 2017
Today's Research Daily features new research reports on 16 major stocks, including General Dynamics (GD), EOG Resources (EOG) and Abbott (ABT). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today. You can see all of today’s research reports here >>>
General Dynamics’ shares have gained +34.6% over the last one year, outperforming the Zacks Aerospace - Defense industry, which increased +20.8% over the same period. The Zacks analyst likes the improved outlook for the company's broad portfolio of products and services given the administration's plans for material spending increases. The expectation is for solid growth momentum post 2017, following the introduction of G500 in 2018, major revenue recognition from Combat Systems’ huge backlog and the Ohio-class Replacement (ORP) submarine program, which should add substantially to the top line by 2019. On the flip side, any slip up in the Trump administration's commitment to raise defense spending remains a headwind for this company as well as many of its peers. Valuation has become an issue as well following the stock's aforementioned run up. (You can read the full research report on General Dynamics here >>>)
EOG Resources shares have gained around +16.1% over the last one year, outperforming the Zacks Oil & Gas E&P Industry, which has lost -9.3% over the same period. The Zacks analyst likes the fact that EOG Resources has premium acreages in three prospective oil plays in the U.S like Permian, Bakken and Eagle Ford shale plays. The company has also decided to complete more wells in 2017, which should contribute to production growth. However, significantly higher exploration expenses incurred during the first three months of this year is cause for concern even though Q1 results were better than expected on the back of volume gains and improved realizations. (You can read the full research report on EOG Resources here >>>)
Abbott shares have outperformed the Zacks Medical sector in the year-to-date period (the stock is up +14% vs. +7.7% gain for the sector) on the back of greater appreciation for the company's strategic repositioning through acquisitions/divestitures. The St. Jude Medical buyout will complement its cardiovascular devices business. Also, the company’s plans to focus on selling its portfolio in core therapeutic areas. Meanwhile, weakness in the nutrition business in China and sluggish growth in the Venezuelan market is a concern. (You can read the full research report on Abbott here >>>)
Other noteworthy reports we are featuring today include Marriott (MAR), Northrop Grumman (NOC) and Symantec (SYMC).
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
It's not the one you think.
See This Ticker Free >>
Director of Research
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here >>>